Our findings further demonstrate that elevated MMP11 expression correlates with heightened expression of immunomodulatory genes, including chemokines, chemokine receptors, MHC molecules, co-stimulatory factors, and co-inhibitory molecules—features strongly associated with favorable responses to cancer immunotherapy (41, 42). The gene discussed is MMP11; the disease is cancer.